Old National Bancorp Repligen Corp Transaction History

Old National Bancorp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$170.78 - $208.42 $21,859 - $26,677	-128 Reduced 7.96%	1,481 $272,000
Q4 2023 Feb 01, 2024	BUY	$114.17 - $185.35 $183,699 - $298,228	1,609 New	1,609 $289,000
Q2 2022 Jul 25, 2022	SELL	$140.68 - $188.02 $183,306 - $244,990	-1,303 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$161.19 - $257.96 $5,964 - $9,544	37 Added 2.92%	1,303 $245,000
Q4 2021 Jan 25, 2022	SELL	$247.59 - $304.47 $9,160 - $11,265	-37 Reduced 2.84%	1,266 $335,000
Q3 2021 Oct 25, 2021	SELL	$194.77 - $324.21 $80,829 - $134,547	-415 Reduced 24.16%	1,303 $377,000
Q2 2021 Jul 26, 2021	BUY	$165.87 - $220.95 $36,657 - $48,829	221 Added 14.76%	1,718 $343,000
Q1 2021 Apr 21, 2021	BUY	$180.37 - $226.26 $29,039 - $36,427	161 Added 12.05%	1,497 $291,000
Q4 2020 Jan 19, 2021	SELL	$148.08 - $206.57 $37,316 - $52,055	-252 Reduced 15.87%	1,336 $256,000
Q3 2020 Oct 29, 2020	BUY	$122.51 - $158.27 $194,545 - $251,332	1,588 New	1,588 $234,000

496

53.9M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.